The Failure of Nicotine Vaping Prescription Policy in Australia

Oct.02.2022
The Failure of Nicotine Vaping Prescription Policy in Australia
Colin Mendelsohn is a smoking cessation expert who helped develop Australia's national smoking cessation guidelines.

Dr. Colin Mendelsohn is a member of the expert advisory group responsible for developing the Australian national smoking cessation guidelines for the RACGP. He is also the founding chairman of the Australian Tobacco Harm Reduction Association, a registered health promotion charitable organization that works to increase awareness of low-risk nicotine products as a smoking alternative for those who are unable to quit smoking.


Dr. Mendelsohn previously served as an Associate Professor at the School of Public Health and Community Medicine at the University of New South Wales from 2016-2020, and as the former Vice Chair of the Australian Association of Smoking Cessation Professionals, the leading body of smoking cessation experts in Australia. According to Dr. Mendelsohn, "The review found that the policy did not achieve its objectives and instead made the situation worse. It created a thriving black market, led to a sharp increase in youth drug use, and made it harder for adult smokers to access legal smoking products.


The use of drugs among young people is increasing rapidly. Illegal and disposable drug products can be easily purchased from tobacco shops, convenience stores, and social media, with law enforcement and prosecution rates being negligible. Instead, teachers are bearing the burden of this policy, with some schools removing bathroom doors and installing e-cigarette detectors to prevent students from using drugs.


Government-funded propaganda campaigns have only disseminated erroneous information about the dangers of electronic cigarette products, and are therefore ineffective in preventing youth from using them.


At the same time, less than 1% of Australian general practitioners are willing to prescribe nicotine, and very few pharmacies distribute electronic cigarette products. Currently, 88-97% of adult electronic cigarette users are using them illegally because they have not obtained a prescription for nicotine.


Australia is the only western country that regulates nicotine consumption products in this way. In countries such as the United States, the United Kingdom, and New Zealand, nicotine inhalers are sold as consumer products to aid adult smokers in quitting and are subject to strict age verification to restrict usage among young people. These laws have proven successful and have greatly contributed to a decrease in smoking rates.


Recently conducted simulation research estimated that by 2080, relaxing current policies would save the lives of 104,000 Australians and prevent over 2 million life years lost. The TGA announced in September 2021 that they would conduct their own review of regulations six months after implementation. However, the review has been postponed with no suggestion of when it will begin.


The main findings of the 12-month pure prescription model review are as follows: 1. A thriving black market has emerged, selling illegal, unregulated, high-nicotine disposable e-cigarette products. 2. Teen drug use has skyrocketed, becoming a crisis for schools and parents nationwide. 3. Access to legal smoking products has become increasingly difficult and expensive for adult smokers, forcing many into the black market or illegal imports without prescriptions. 4. This model has faced opposition from smokers and drug users, causing a catastrophic loss of confidence and trust in public health. 5. Currently, almost all e-cigarette products are purchased on the black market or from overseas, meaning they do not need to pay taxes to the Australian government.


Based on the failure of this policy, the following suggestions have been made: 1. exempt liquid nicotine with a concentration of ≤6% from poison standards and allow it to be used as a harm reduction measure for smoking tobacco. 2. Allow licensed retailers to sell these products and strictly verify the age of buyers. 3. Allow the ACCC to supervise and regulate the industry. Dr. Mendelsohn summarizes, "The Australian government's prescription model for nicotine e-cigarettes is a clear and foreseeable public health policy failure. The black market is expanding at an alarming rate nationwide, and young people are taking up harmful drugs quickly. Meanwhile, adult smokers who could live longer and healthier lives by switching to vaping products are forced to compete with the same black market or continue to smoke more harmful traditional cigarettes sold on every street corner.


Australia urgently needs to catch up with other Western countries by allowing adult smokers access to nicotine vaping products while implementing strict restrictions on their use by minors. Without immediate action, the black market will continue to grow leading to more smoking-related deaths and a continued increase in youth vaping rates.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness and accuracy of the article's content. The translation of this article is solely for industry communication and research.


Due to limitations in the level of translation, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.


2FIRSTS fully aligns with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign issues and positions.


Information compiled in this article belongs to the original media and authors. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

French Lawmakers Move to Extend Plain Packaging Rules to Vaping Product
French Lawmakers Move to Extend Plain Packaging Rules to Vaping Product
French lawmakers Nicolas Thierry and Pierre Cazenave said on April 15 that they will file a cross-party bill to extend plain packaging requirements to vaping products. Under the proposal, unit packs and outer packaging for vaping products, including those without nicotine, would become neutral and standardized in the same way cigarette packs have been since 2017.
Apr.16 by 2FIRSTS.ai
PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
On April 22, 2026, Philip Morris International released its first-quarter 2026 results. The report showed net revenues of $10.146 billion, up 9.1% year on year; adjusted diluted EPS of $1.96, up 16.0%; and smoke-free products accounting for 43% of total net revenues. Based on first-quarter performance, the company raised its 2026 full-year adjusted diluted EPS forecast to $8.36 to $8.51, or $8.11 to $8.26 excluding currency.
Apr.23 by 2FIRSTS.ai
FDA Authorizes Glas Vape but Flavor Hopes Fall Short
FDA Authorizes Glas Vape but Flavor Hopes Fall Short
The FDA has added Glas products to its authorized electronic nicotine delivery systems (ENDS) list, granting Marketing Granted Orders (MGOs) to the Glas G DEVICE and a BLONDE TOBACCO pod. The decision expands the number of FDA-authorized ENDS products to 41, marking the first new authorization since Juul’s approvals in July 2025. However, widely anticipated non-tobacco flavored products were not approved.
Mar.13
JTI UK Updates Nordic Spirit Packaging to Strengthen “Strength and Flavour” Guidance
JTI UK Updates Nordic Spirit Packaging to Strengthen “Strength and Flavour” Guidance
Japan Tobacco International UK (JTI UK) has unveiled a refreshed brand identity for Nordic Spirit nicotine pouches. The new packaging is now live on JTI360 and will roll out to shelves over the coming months. The updated design strengthens on-pack guidance on strength and flavour, adding slower/faster release cues and a six-dot strength system (6–17mg). Each can contains 20 pouches and includes a lid compartment for storing used pouches before disposal.
Mar.04 by 2FIRSTS.ai
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai
Turkey’s New Tobacco Bill Draft Would Cover E-Cigarettes and Heated Tobacco Products
Turkey’s New Tobacco Bill Draft Would Cover E-Cigarettes and Heated Tobacco Products
A Turkey’s draft would impose major limits on the use of tobacco products in public buildings, educational and healthcare institutions, children’s areas, and outdoor events, while setting a 2040 target for a complete ban on the production, sale, and consumption of tobacco products. The draft also broadens the definition of tobacco products to include e-cigarettes, heated tobacco products, and all nicotine-containing systems.
Apr.13 by 2FIRSTS.ai